Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 20:39:56 +0200Wed, 17 Jul 2024 16:48:00 +0200Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/voxzogoHuman medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/voxzogoWed, 17 Jul 2024 16:48:00 +0200Human medicineVoxzogo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5475-en_0_1.pdfVoxzogo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5475-en_0_1.pdfWed, 17 Jul 2024 16:29:00 +0200Human medicine